| 摘要 |
The disclosure relates to novel luliberin analogues which possess luliberin agonist activity, to processes for their manufacture and to compositions containing them. Typical of the peptides disclosed is <IMAGE> in which A is D-Phe, D-Tyr(Me) or D-Ser(But). |
